U.S. Secret Service Relaxes Past-Use Cannabis Policy for Applicants
by Mary E.
France has officially permitted medical cannabis production and cultivation. The European Country stands to develop a thriving domestic sector with this latest move, which was enforced on March 1 following the earlier publication of a decree in the Official Journal.
Prior to the decree’s publication, France had already been busy importing cannabis products for its medical cannabis pilot program. The decree has been made public in an effort “to allow the creation of a sector ranging from cultivation to medicine based on cannabis for medical use in France.”
However, more regulations are required to establish a robust medical cannabis system in France. Regulators must first implement the decree before it can fully take effect. In regards to the guidelines and procedures by which cannabis should be cultivated and produced countrywide, the current legislation does not extend beyond the scope of medical use.
The decree may have only revised certain segments of France’s Code of Public Health, such as sections to permit cannabis imports/exports, cultivation, production, manufacturing, transportation, and possession of the plant and its derivatives, but it is sure to have a major impact on the industry at large. The development of a medically-authorized supply chain will be overseen by the National Agency for the Safety of Medicines and Health Products (ANSM).
On Thursday, February 17, the ANSM announced the launch of a non-permanent scientific committee tasked with clarifying the rules surrounding the use and sale of all French-produced cannabis medicine. A panel of 11 committee members have been chosen by the ANSM to assess various facets of the medical cannabis supply chain in France, such as pharmaceutical quality criteria, track-and-trace systems, and the benefits of ingesting medical cannabis, as well as the THC/CBD potencies and identification of strains made available for medical purposes.
The ANSM has been leading a strictly regulated medical cannabis pilot program for the best part of a year. The pilot program, which involves participation from approximately 3,000 patients who suffer from debilitating conditions, extends until March 2023. Medical cannabis was imported into France from overseas to support the country’s pilot project. It is unclear whether or not French cannabis companies will maintain their involvement in the medical industry that is set to be developed by the ANSM.
The ANSM’s 11 members come from a handful of different ministries. Moreover, some of them are representatives from the Conseil Order of Pharmacists and the National Research Institute for Agriculture, Food, and the Environment. Since the agency is expected to serve as the sole industrial operator for delegating medical cannabis production in France, industry experts envision the ANSM selecting a lone industrial operator who can deal with everything production-related. Consequently, this could result in less medical cannabis being produced.
In the event that this happens, France’s medical cannabis market could somewhat mirror the Italian medical industry, which is currently slacking in terms of domestic production. Due to Italy’s low production, overseas imports are necessary to keep the country’s industry afloat.
In comparison with other countries on the European map, France’s rate of medical cannabis consumption is significantly higher. According to Statista, 1.5 million French people used cannabis on a regular basis in 2019. Nonetheless, it is unlikely that a recreational cannabis program will be implemented at this point in time. Current laws stipulate that anyone who possesses cannabis in France may be faced with a prison sentence of one year and a penalty of more than $4,000. More penalties face individuals who illegally import, export, transport, deliver, and supply the plant.
In 2020, the people of France were informed that they would face an on-the-spot fine of €200 (USD$220) for being caught with cannabis. This fee shrinks to €150 (USD$165) if paid within a 15-day period or inflates to €450 (USD$500) if paid in full after 45 days.
The political roadblocks that are preventing cannabis policy from being updated may prevent the French medical cannabis industry from finding firm ground. With that being said, it remains uncertain as to how exactly the French medical cannabis market will roll out.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…
Experts are taking a bird’s eye view of an exciting and rapidly evolving area in cannabis research known as the endocannabinoidome (eCBome)….
Spliffs and joints, while similar, are different cannabis products rolled up in paper. If you are a seasoned cannabis smoker, you’re probably…
April 14, 2022 at 8:24 am
I love Veriheal ❤️ 😍 💖